Drug Information

Drug General Information
Drug ID
D00TUR
Former ID
DNCL001602
Drug Name
LY2495655
Indication Disuse muscle atrophy; Cancercachexia [ICD9: 140-229, 799.4; ICD10:R64] Phase 2 [523751]
Company
Eli Lilly
Target and Pathway
Target(s) Growth/differentiation factor 8 Target Info Modulator [544346]
PANTHER Pathway TGF-beta signaling pathway
WikiPathways Hypertrophy Model
References
Ref 523751ClinicalTrials.gov (NCT01505530) A Phase 2 Study of LY2495655 in Participants With Pancreatic Cancer. U.S. National Institutes of Health.
Ref 544346Myostatin inhibitors as therapies for muscle wasting associated with cancer and other disorders. Curr Opin Support Palliat Care. 2013 November; 7(4): 352-360.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.